Table 3.
Mutation/ Syndrome |
Defect | Onset/Age at Presentation |
Hepatic Presentation | Neurological Features | Other Features | Diagnostic Tests |
---|---|---|---|---|---|---|
DGUOK (17-19) | mtDNA depletion Complex I, III, IV |
Acute/early neonatal |
Neonatal liver failure, progressive, cholestasis, mimic neonatal hemochromatosis, hepatocellular carcinoma risk, can have isolated liver disease |
Hypotonia, developmental regression, nystagmus |
Lactic acidosis, hypoglycemia |
DGUOK sequence analysis |
POLG (15, 16) | mtDNA depletion Complex I, III, IV |
Acute/neonatal | Neonatal liver failure, micro- or macro-vesicular steatosis, cirrhosis |
Encephalopathy, seizures,, myopathy, neuropathy, blindness, developmental regression |
Vomiting, GERD |
POLG sequence analysis or panel |
MPV17/Navajo neuro-hepatopathy (20, 21) |
mtDNA depletion Complex I, III, IV |
Acute/neonatal | Isolated neonatal/infant liver failure or in multisystem syndrome |
Sensorimotor neuropathy, progressive CNS white matter lesions |
Acidosis, FTT, corneal anesthesia,/abrasions, acral mutilation |
MPV 17 sequence analysis or panel |
TWINKLE(PEO1) (C10ORF2) (5, 23) |
mtDNA depletion DNA helicase |
Acute/neonatal | Neonatal liver failure, cirrhosis, elevated liver enzymes |
Encephalopathy (athetosis, ataxia, seizures), sensory neuropathy, deafness |
C10ORF2 TWINKLE sequence analysis |
|
TRMU (31, 32) | Decreased mito translation (tRNA modifying enzyme) Complex I, III, IV |
Acute/neonatal | Neonatal liver failure, some recover, possibly with cirrhosis |
TRMU sequence analysis |
||
TSFM, EFG1, EF- Tu, MRPS16 (37) |
Decreased mito translation (elongation) |
Acute/neonatal | Liver dysfunction in infancy, hepatomegaly |
Hypotonia, dystonia | Hypertrophic cardiomyopathy, tubulopathy |
Sequencing individual genes e.g., TSFM or exome sequencing |
SUCLG1 (22) | mtDNA depletion abnormal succinate synthesis Complex I, III, IV |
Acute/neonatal | Neonatal liver failure, episodic liver failure |
Hypotonia/myopathy (progressive), hearing loss |
Acidosis, elevated methylmalonic acid |
SUCLG1 sequence analysis |
BCS1L (35) | Complex III assembly deficiency |
Acute/neonatal | Neonatal liver failure, cholestasis, hepatic iron overload |
Growth failure, amino- aciduria, lactic acidosis, early death (GRACILE syndrome) |
BCS1L sequence analysis |
|
SCO1 (36) | Complex IV deficiency |
Acute/neonatal | Neonatal liver failure, hepatomegaly |
Hypotonia | Acidosis | SCO1 sequence analysis |
FARS2 (41) | Phenylalanyl tRNA synthetase |
Acute/neonatal | Neonatal liver failure (Alper’s like) |
Intractable seizures, encephalopathy |
FARS2 sequence analysis on Nexgen |
|
SLC25A20 (29) | Carnitine acylcarnitine translocase deficiency CACT deficiency (carnitine, FAO) |
Acute/neonatal | Neonatal liver failure, steatohepatitis |
Myopathy | Hypoglycemia, cardiomyopathy |
SLC25A20 sequence analysis |
HADHA/ LCHAD or tri-functional protein deficiency (25) |
FAO defect | Acute | Hepatomegaly, fatty liver, elevated LFTs, cholestasis, liver failure, AFLP |
Encephalopathy, peripheral neuropathy |
Acidosis, hypoglycemia, pigmentary retinopathy |
HADHA sequence analysis |
CPTI deficiency (26) |
Carnitine cycle FAO defect |
Acute/infancy | Hepatomegaly, liver failure episodes |
Reye’s-like episodes of encephalopathy |
Hypoketotic hypoglycemia |
CPT IA sequence analysis |
CPT II deficiency (26, 27) |
Carnitine cycle FAO defect |
Acute/severe neonatal |
Liver failure in infancy | Seizures | Hypoketotic hypoglycemia, cardiomyopathy, myopathy |
CPT II sequence analysis |